NCT03418090View on ClinicalTrials.gov

Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Transplant

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 17, 2018

Primary Completion Date

November 4, 2019

Study Completion Date

November 4, 2019

Conditions
Pulmonary Surgical Procedures
Interventions
DRUG

129Xe MRI

Evaluation of pulmonary function

DRUG

133XE scintigraphy

Evaluation of pulmonary function

Trial Locations (2)

22908

University of Virginia, Charlottesville

27710

Duke University Hospital, Durham

Sponsors

Lead Sponsor

Polarean, Inc.
All Listed Sponsors
lead

Polarean, Inc.

INDUSTRY